Controversies in the management of asymptomatic carotid stenosis: from best medical therapy to a redefinition of surgical indications - Report - MDSpire

Controversies in the management of asymptomatic carotid stenosis: from best medical therapy to a redefinition of surgical indications

  • By

  • Jianghao Zhou

  • Wei Zhu

  • Yong Lu

  • Huiming Dou

  • Guochu Peng

  • Changyang Zhong

  • July 2, 2026

  • 0 min

Share

Clinical Report: Debates Surrounding the Treatment of Asymptomatic Carotid Stenosis

Background

Asymptomatic carotid artery stenosis is increasingly diagnosed due to aging populations and advanced imaging techniques. Understanding the balance between surgical interventions and medical therapy is crucial for optimizing patient outcomes.

Data Highlights

No numerical data available in the source material.

Key Findings

  • Recent trials, including ACST-2, ECST-2, and CREST-2, question the reliance on luminal stenosis for intervention decisions.
  • Best medical therapy has evolved with intensive lipid-lowering strategies and novel glucose-lowering agents.
  • The prevalence of aCAS increases significantly with age, particularly in men over 80 years.
  • Historical trials established carotid endarterectomy as a treatment option, but benefits were limited to specific demographics.
  • Emerging biomarkers and imaging techniques may better identify high-risk patients.

Clinical Implications

Clinicians should consider the evolving landscape of medical therapy when assessing treatment options for aCAS. Individualized risk assessment incorporating multimodal biomarkers may enhance decision-making regarding surgical interventions.

Conclusion

The management of asymptomatic carotid artery stenosis is transitioning towards a more nuanced approach that integrates biological risk factors and contemporary medical therapies, necessitating ongoing evaluation of intervention criteria.

Related Resources & Content

  1. 2024 Guideline for the Primary Prevention of Stroke: A Guideline From the American Heart Association/American Stroke Association
  2. Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy - PMC
  3. sentara — Carotid Endarterectomy: Surgical Treatment for Symptomatic Carotid Artery Disease
  4. Frontiers in Cardiovascular Medicine — Transcervical carotid artery stenting compared to transfemoral carotid artery stenting and carotid endarterectomy: perioperative and short-term results from a single center
  5. Journal of Endovascular Therapy — In-Stent Stenosis or Occlusion After Carotid Artery Stenting in Patients Treated With Anticoagulants vs Antiplatelet Therapy
  6. baptist health south florida — Jose “Pepe” Alvarez Jr., M.D., Memorial Lecture on Vascular Disease: Modern Approaches to Managing Carotid Disease
  7. Carotid Endarterectomy: Surgical Treatment for Symptomatic Carotid Artery Disease
  8. Transcervical carotid artery stenting compared to transfemoral carotid artery stenting and carotid endarterectomy: perioperative and short-term results from a single center
  9. 2024 Guideline for the Primary Prevention of Stroke: A Guideline From the American Heart Association/American Stroke Association
  10. Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy - PMC
  11. NCA - Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with Stenting (CAG-00085R8) - Decision Memo

Original Source(s)

Related Content